List of Excipients in API ELTROMBOPAG OLAMINE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ELTROMBOPAG OLAMINE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | PROMACTA | eltrombopag olamine | 0078-0684 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | PROMACTA | eltrombopag olamine | 0078-0684 | FERRIC OXIDE RED | |
| Novartis Pharmaceuticals Corporation | PROMACTA | eltrombopag olamine | 0078-0684 | FERROSOFERRIC OXIDE | |
| Novartis Pharmaceuticals Corporation | PROMACTA | eltrombopag olamine | 0078-0684 | HYPROMELLOSES | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ELTROMBOPAG OLAMINE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ELTROMBOPAG OLAMINE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
ELTROMBOPAG OLAMINE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
ELTROMBOPAG OLAMINE drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
ELTROMBOPAG OLAMINE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ELTROMBOPAG OLAMINE drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
ELTROMBOPAG OLAMINE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
ELTROMBOPAG OLAMINE drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
ELTROMBOPAG OLAMINE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ELTROMBOPAG OLAMINE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ELTROMBOPAG OLAMINE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | eltrombopag olamine | 0078-0684 |
| >Company | >Ingredient | >NDC |
ELTROMBOPAG OLAMINE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
